COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article Access statistics

Viewed: 627

Emailed: 0

PDF Downloaded: 186

IP International Journal of Medical Microbiology and Tropical Diseases

De novo daptomycin non-susceptible enterococci causing urinary tract infection: a study from north India

Full Text PDF Share on Facebook Share on Twitter

Author Details : Neelam Taneja, Shubha Garg, Shreya Singh, Suma B Appannanavar, Balvinder Mohan

Volume : 4, Issue : 1, Year : 2018

Article Page : 36-41

Suggest article by email


Introduction: Daptomycin is a bactericidal agent active against vancomycin resistant enterococci (VRE) which are emergent nosocomial uropathogens. There is limited data available on daptomycin non-susceptible enterococci (DNSE) in India. Herein we describe the emergence of de novo DNSE causing urinary tract infections (UTI) from India.
Materials and Methods: We prospectively screened, consecutive enterococci (n=140) grown in significant numbers (≥105cfu/ml) from urine cultures in hospitalized patients (n=12434) over 6 months. Isolates with daptomycin minimum inhibitory concentration (MIC) >4µg/ml by E-test and no history of daptomycin exposure were defined as DNSE. Colonization and symptomatic UTI was defined as per the Centre for Disease Control and Prevention guidelines.
Results: Prevalence of DNSE was 12.1% (17/140) and all were E. faecium. In 6 cases (35.2%) DNSE isolates were colonizers while 11(64.71%) were from UTI cases. Urosepsis occurred in 4 cases, of which 3 died. History of immunocompromise, recent urogenital surgery and indwelling per-urethral catheter were present in 47%, 58.8% and 64.7% cases respectively. Exposure to third generation cephalosporin and metronidazole was seen in nine (52.9%) and 3 (17.65%) cases respectively, while one patient each had vancomycin and teicoplanin exposure. Daptomycin MIC range was 6 to >256 µg/ml. Resistance to ciproflocaxin, amoxicillin, high level gentamicin, tetracycline, nitrofurantoin and vancomycin was seen in 100%, 94.1%, 88.2%, 52.9%, 41.1% and 23.5% respectively. All DNSE were susceptible to linezolid.
Conclusions: A high prevalence of DNSE warrants further case control studies, molecular and epidemiological studies to elucidate the risk factors, molecular mechanisms of resistance and epidemiological origin of these isolates.

Keywords: De novo, Daptomycin, Enterococci, UTI, India.

Doi : 10.18231/2455-6807.2018.0008

How to cite : Taneja N, Garg S, Singh S, Appannanavar S B, Mohan B, De novo daptomycin non-susceptible enterococci causing urinary tract infection: a study from north India. IP Int J Med Microbiol Trop Dis 2018;4(1):36-41

Copyright © 2018 by author(s) and IP Int J Med Microbiol Trop Dis. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (